Insider selling
Traded Nov 12 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Exagen sold $509K of Exagen shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Nov 13, 2026 · Filed Nov 13, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider selling
Traded Nov 12 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Exagen sold $509K of Exagen shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 13 · filed 1 day laterNot reported under a pre-arranged trading plan
A major shareholder of Exagen sold $237K of Exagen shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.